Evidence map›Paper›PMID 26097550›Full record

ArticleInternational journal of clinical and experimental pathology2015

Golgi phosphoprotein 3 regulates metastasis of prostate cancer via matrix metalloproteinase 9.

Wenzhi Li, Kai Qi, Zhanyu Wang, Meng Gu, Gang Chen, Fengfu Guo, Zhong Wang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2019
    Review
  9. Review
  10. Article
  11. Article
  12. Effect of AQP9 Expression in Androgen-Independent Prostate Cancer Cell PC3.International journal of molecular sciences · 2016
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Wenzhi LiDepartment of Urology, Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200011, China ; Department of Urology, Linyi People's Hospital Linyi 276000, China.
Kai QiDepartment of Urology, Linyi People's Hospital Linyi 276000, China.
Zhanyu WangDepartment of Urology, Jinshan Hospital, Fudan University Shanghai 201508, China.
Meng GuDepartment of Urology, Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200011, China.
Gang ChenDepartment of Urology, Jinshan Hospital, Fudan University Shanghai 201508, China.
Fengfu GuoDepartment of Urology, Linyi People's Hospital Linyi 276000, China.
Zhong WangDepartment of Urology, Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200011, China.
Jinshan Hospital of Fudan University · CNShanghai Ninth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies suggest that Golgi phosphoprotein 3 (GOLPH3) protein is a candidate metastasis gene in human cancer. The goal of this study was to determine the function of GOLPH3 in prostate cancer metastasis and to identify GOLPH3-regulated pathways and genes involved in prostate cancer metastasis. GOLPH3 expression was detected in prostate cancer. To investigate its function, PC-3 cells were stably transfected with shRNA targeting GOLPH3. Cell abilities of invasion and migration were measured in vitro. Downstream regulatory pathways of GOLPH3 were characterized using quantitative RT-PCR and Western blotting analysis. Immunohistochemical studies in prostate cancer specimens revealed a positive correlation of GOLPH3 expression with prostate cancer. GOLPH3 was expressed in prostate cancer cell lines. GOLPH3 repression resulted in the reduction of mRNA level and protein level of MMP9, accompanied with reduced phosphorylation of mTOR, EGFR and Src. Our findings suggest GOLPH3 regulate MMP9 expression which impact cell migration and invasion. This regulation is probably mediated by EGFR and Src signaling pathways.

Indexed as

Cell Line, TumorCell MovementErbB ReceptorsGene Expression Regulation, NeoplasticHumansMaleMatrix Metalloproteinase 9Membrane ProteinsNeoplasm MetastasisPhosphorylationProstatic NeoplasmsSignal Transductionsrc-Family KinasesTOR Serine-Threonine KinasesErbB ReceptorsGOLPH3 protein, humanMatrix Metalloproteinase 9Membrane ProteinsMTOR protein, humansrc-Family KinasesTOR Serine-Threonine KinasesEGFRGOLPH3metastasisMMP9mTORprostate cancer

Identifiers

PMID26097550
PMCPMC4466937
OpenAlexW2417937612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.